INDIANAPOLIS - JUNE 17: Researchers at Lilly Research Laboratories, shown here on June 17, 2014, developed basal insulin peglisp


INDIANAPOLIS - JUNE 17: Researchers at Lilly Research Laboratories, shown here on June 17, 2014, developed basal insulin peglispro, a diabetes molecule undergoing Phase 3 clinical trials.


Size: 4928px × 3264px
Location: Indianapolis, IN
Photo credit: © Susan Montgomery / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: building, business, corporation, diabetes, eli, headquarters, indiana, indianapolis, industrial, industry, lilly, manufacturing, medicine, pharmaceutical, pharmaceuticals, research, technology